1997;388:300C4
1997;388:300C4. NSCLC cellular models. Consistent with our observations, this drug combination also significantly reduces tumor growth 4, mean SD) (A, B). H1975, PC9 and A549 cells treated with 5, 50, 500 nM RO3280 or 2, 20, 200 ng/ml rhTRAIL for 24 hours were prepared for western blot analysis to determine PARP cleavage levels (C, D).…